Financials Zhende Medical Co., Ltd.

Equities

603301

CNE100003J31

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
20.62 CNY +0.10% Intraday chart for Zhende Medical Co., Ltd. +7.79% -15.84%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,045 13,491 11,564 10,059 6,477 5,451 - -
Enterprise Value (EV) 1 3,045 13,491 11,564 10,059 6,477 5,451 5,451 5,451
P/E ratio 19.6 x 5 x 19.5 x 13.3 x 33.1 x 11.4 x 8.97 x -
Yield - 3.68% 1.17% 1.97% 2.04% 2.18% 2.81% -
Capitalization / Revenue - 1.3 x 2.27 x 1.64 x 1.57 x 1.15 x 0.97 x -
EV / Revenue - 1.3 x 2.27 x 1.64 x 1.57 x 1.15 x 0.97 x -
EV / EBITDA - - - 10,066,261 x - - - -
EV / FCF - - - - -48.1 x -25.7 x -839 x 53.8 x
FCF Yield - - - - -2.08% -3.88% -0.12% 1.86%
Price to Book - 3.4 x 2.84 x 1.63 x 1.22 x 0.92 x 0.85 x -
Nbr of stocks (in thousands) 196,000 215,748 225,105 264,351 264,351 264,351 - -
Reference price 2 15.54 62.53 51.37 38.05 24.50 20.62 20.62 20.62
Announcement Date 4/29/20 4/27/21 3/29/22 4/25/23 4/26/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 10,399 5,092 6,138 4,127 4,740 5,630 -
EBITDA - - - 999.2 - - - -
EBIT 1 - 3,537 822 812.8 225.9 552 700 -
Operating Margin - 34.01% 16.14% 13.24% 5.47% 11.65% 12.43% -
Earnings before Tax (EBT) 1 - 3,533 819.9 801.7 218.9 546 692 -
Net income 1 156.9 2,549 595.9 681.1 198.4 480 610 -
Net margin - 24.52% 11.7% 11.1% 4.81% 10.13% 10.83% -
EPS 2 0.7929 12.50 2.630 2.870 0.7400 1.810 2.300 -
Free Cash Flow 1 - - - - -134.5 -211.7 -6.5 101.3
FCF margin - - - - -3.26% -4.47% -0.12% -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - 2.300 0.6000 0.7500 0.5000 0.4500 0.5800 -
Announcement Date 4/29/20 4/27/21 3/29/22 4/25/23 4/26/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - - - -135 -212 -6.5 101
ROE (net income / shareholders' equity) - 94.9% 16.2% 14.2% 3.6% 8% 9% -
ROA (Net income/ Total Assets) - - - 9.51% - - - -
Assets 1 - - - 7,159 - - - -
Book Value Per Share 2 - 18.40 18.10 23.40 20.10 22.50 24.30 -
Cash Flow per Share - 13.70 - 5.250 - - - -
Capex 1 - 1,093 689 745 587 913 1,004 1,004
Capex / Sales - 10.51% 13.53% 12.13% 14.21% 19.25% 17.83% -
Announcement Date 4/29/20 4/27/21 3/29/22 4/25/23 4/26/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
20.62 CNY
Average target price
28 CNY
Spread / Average Target
+35.77%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 603301 Stock
  4. Financials Zhende Medical Co., Ltd.